KYLA TERESINSKI: Open Payments
NPI 1013788397 · WAUSAU, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$925 in 66 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $622 · 2025 $925
Food & beverage: $830Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $195 |
| UCB, Inc. | 17 | $187 |
| Janssen Biotech, Inc. | 7 | $172 |
| Regeneron Healthcare Solutions, Inc. | 5 | $138 |
| Organon LLC | 9 | $76 |
| GENZYME CORPORATION | 3 | $46 |
| Amgen Inc. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Lilly USA, LLC | 1 | $27 |
Products named: Bimzelx, DUPIXENT, SKYRIZI, TREMFYA, OTEZLA, Sotyktu, TALTZ, RINVOQ.
Industry payments across WI — which companies pay providers there.
